Testicular cancer survival in Estonia: Improving but still relatively low

References

• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, . EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, . EUROCARE-3: Survival of cancer patients diagnosed 1990–94 – results and commentary. Ann Oncol 2003;14(Suppl 5):v61–118.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0, Lyon: IARCPress; 2004.
   Google Scholar
• Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. Int J Cancer 2006;118:3099–111.
   PubMed Web of Science ®Google Scholar
• Aareleid T, Brenner H. Trends in cancer patient survival in Estonia before and after the transition from a Soviet republic to an open market economy. Int J Cancer 2002;102:45–50.
   PubMed Web of Science ®Google Scholar
• Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG, . Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 2008;44:1463–75.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for ‘up-to-date’ cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004;40:326–35.
   PubMed Web of Science ®Google Scholar
• Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961;6:101–21.
   PubMedGoogle Scholar
• Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epid 2006;164:689–96.
   PubMed Web of Science ®Google Scholar
• Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004;40:2494–501.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Model based hybrid analysis of cancer patient survival. Eur J Cancer 2007;43:921–7.
   PubMedGoogle Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4:87–90.
   PubMed Web of Science ®Google Scholar
• Gondos A, Bray F, Hakulinen T, Brenner H, the EUNICE Survival Working Group. Trends in cancer survival in 11 European populations from 1990 to 2009: A model-based analysis. Ann Oncol 2009;20:564–73.
   PubMed Web of Science ®Google Scholar
• Spermon JR, Witjes JA, Kiemeney LA. Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor. Urology 2002;60:889–93.
   PubMedGoogle Scholar
• Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, . Guidelines on testicular cancer. European Association of Urology 2009. Available from: http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/Testis_Cancer.pdf.
   Google Scholar
• Gilbert SM, Daignault S, Weizer AZ, Wei JT, Hollenbeck BK. The use of tumor markers in testis cancer in the United States: A potential quality issue. Urol Oncol 2008;26:153–7.
   PubMed Web of Science ®Google Scholar
• Sohaib SA, Koh DM, Husband JE. The role of imaging in the diagnosis, staging, and management of testicular cancer. Am J Roentgenol 2008;191:387–95.
   PubMed Web of Science ®Google Scholar
• Agnarsson BA, Gudbjartsson T, Einarsson GV, Magnusson K, Thoroddsen A, Bergthorsson JT, . Testicular germ cell tumours in Iceland: A nationwide clinicopathological study. APMIS 2006;114:779–83.
   PubMedGoogle Scholar
• Sant M, Aareleid T, Artioli ME, Berrino F, Coebergh JW, Colonna M, . Ten-year survival and risk of relapse for testicular cancer: A EUROCARE high resolution study. Eur J Cancer 2007;43:585–92.
   PubMed Web of Science ®Google Scholar
• Stephenson AJ, Sheinfeld J. The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol 2004;22:225–33.
   PubMedGoogle Scholar
• Bernal F, Raman JD. Exploration of treatment options for the management of stage I testicular seminoma. Expert Rev Anticancer Ther 2008;8:1081–90.
   PubMed Web of Science ®Google Scholar
• Huddart RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther 2005;5:123–38.
   PubMed Web of Science ®Google Scholar